structure of [(1-Isobutylpiperidin-3-yl)methyl]amine

[(1-Isobutylpiperidin-3-yl)methyl]amine

CAS No.: 1000416-60-3
M. Wt: 170.30
M. Fa: C10H22N2
InChI Key: AFYKCTGWHMTWLK-UHFFFAOYSA-N

Names and Identifiers of [(1-Isobutylpiperidin-3-yl)methyl]amine

CAS Number

1000416-60-3

IUPAC Name

[1-(2-methylpropyl)piperidin-3-yl]methanamine

InChI

InChI=1S/C10H22N2/c1-9(2)7-12-5-3-4-10(6-11)8-12/h9-10H,3-8,11H2,1-2H3

InChIKey

AFYKCTGWHMTWLK-UHFFFAOYSA-N

Canonical SMILES

CC(C)CN1CCCC(C1)CN

Physical and chemical properties of [(1-Isobutylpiperidin-3-yl)methyl]amine

Molecular Formula

C10H22N2

Molecular Weight

170.30

Safety Information of [(1-Isobutylpiperidin-3-yl)methyl]amine

Pictograms

Signal Word

 Danger

Safety Data Sheet
Supports customized editing of SDS information and downloading in PDF documents.

Applications of [(1-Isobutylpiperidin-3-yl)methyl]amine

[(1-Isobutylpiperidin-3-yl)methyl]amine has several applications:

  • Pharmaceutical Development: It serves as a scaffold for synthesizing novel drugs targeting central nervous system disorders.
  • Chemical Research: The compound is utilized in studies exploring structure-activity relationships within medicinal chemistry.
  • Biochemical Assays: It may be used as a probe to investigate enzyme activity or receptor interactions.

Interaction Studies of [(1-Isobutylpiperidin-3-yl)methyl]amine

Interaction studies involving [(1-Isobutylpiperidin-3-yl)methyl]amine focus on its binding affinity to various biological targets:

  • Receptor Binding: Research has demonstrated that this compound can bind effectively to serotonin and dopamine receptors, suggesting its potential role as a psychoactive agent.
  • Enzyme Inhibition: Preliminary studies indicate that it may inhibit certain enzymes involved in neurotransmitter metabolism, enhancing its therapeutic profile.

These interactions are crucial for understanding the compound's pharmacodynamics and potential side effects.

Biological Activity of [(1-Isobutylpiperidin-3-yl)methyl]amine

The biological activity of [(1-Isobutylpiperidin-3-yl)methyl]amine has been explored in various studies, indicating its potential as a pharmacologically active agent. Its interactions with neurotransmitter receptors suggest possible applications in treating neurological disorders. The compound may exhibit:

  • Antidepressant Effects: Similar compounds have shown efficacy in modulating serotonin and norepinephrine levels.
  • Analgesic Properties: Its structural similarity to known analgesics indicates potential pain-relieving effects.

Research into its mechanism of action is ongoing, with studies focusing on its binding affinity to specific receptors and enzymes.